WHWK - Whitehawk Therapeutics, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 2.0 0.09 (4.47%) | --- | 0.0 (0.0%) | -0.01 (-0.48%) | -0.02 (-1.03%) | 0.09 (4.5%) | 0.01 (0.51%) | 0.0 (0.0%) |
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.76
- Diluted EPS:
- -0.76
- Basic P/E:
- -2.75
- Diluted P/E:
- -2.75
- RSI(14) 1m:
- 50.0
- VWAP:
- 2.08
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|